Clinical trials: Stage 3 Acute Kidney Injury
Empagliflozin in Post AKI Stage 2-3
The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors
Effects of Empagliflozin compared with placebo in post severe acute kidney injury survivors, evaluated by MAKE365.
- Trial name
- NCT05360615
- Testing
- Empagliflozin 10 MG
- Where
- Thailand
- Volunteers
- 147 people
- Sponsor
- Chulalongkorn University